HRT Financial’s INNOVATE Corp VATE Stock Holding History

HRT Financial’s Portfolio VATE Stock Details VATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,357	Closed	-$277K	–	3324
2023 Q1	$277K	Buy	+9,357	New	+$273K	﹤0.01%	1754
2021 Q4	–	Sell	-9,840	Closed	-$403K	–	4138
2021 Q3	$403K	Buy	+9,840	New	+$368K	﹤0.01%	2204

Other funds holding VATE

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

WCM

Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

HRT Financial's VATE Position: Q2 2023 in Review

HRT Financial sold out of INNOVATE Corp (VATE) in Q2 2023, closing a stake of 9,357 shares — an estimated $277K sold.

HRT Financial first reported a position in VATE in Q3 2021 and held it in 2 quarters. The position peaked at $403K in Q3 2021. 58 funds tracked by Wall St. Rank hold VATE as of Q2 2023.

HRT Financial reported no remaining INNOVATE Corp position as of Q2 2023 after selling out during the quarter.
HRT Financial sold 9,357 INNOVATE Corp shares in Q2 2023, an estimated $277K.
HRT Financial first reported a position in INNOVATE Corp in Q3 2021 and held it in 2 quarters.
HRT Financial's INNOVATE Corp position peaked at $403K in Q3 2021.
58 funds tracked by Wall St. Rank held INNOVATE Corp as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.